Testicular Leukemia (DBCOND0053648)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02883049	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations	Asparaginase Escherichia coli Beta-D-Glucose Calcium Clofarabine Cortisone Cyclophosphamide Cytarabine Dasatinib Daunorubicin Dexamethasone Doxorubicin Ethanol Etoposide Hydrocortisone Hydrocortisone succinate Leucovorin Levoleucovorin Mercaptopurine Methopterin Methotrexate Pegaspargase Prednisone Sodium succinate Sulfate ion Tioguanine Vincristine	treatment	3	active_not_recruiting
NCT03959085	Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy	Asparaginase Escherichia coli Benzalkonium Calaspargase pegol Calcium Carbonate ion Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Doxorubicin Hydrocortisone Inotuzumab ozogamicin Leucovorin Levoleucovorin Mercaptopurine Methopterin Methotrexate Pegaspargase Prednisolone Prednisone Sulfate ion Tioguanine Vincristine	treatment	3	recruiting
NCT01406756	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Beta-D-Glucose Calcium Clofarabine Clofarabine Cortisone Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Ethanol Etoposide Hydrocortisone Hydrocortisone succinate Leucovorin Levoleucovorin Mercaptopurine Methopterin Methotrexate Pegaspargase Prednisone Sodium succinate Sulfate ion Tioguanine Vincristine	treatment	3	recruiting